Yahoo! Finance Search - Finance Home - Yahoo! - Help

Sunday, April 19 2015 7:02am ET - U.S. Markets Closed.
Industry Center - Drugs - Generic
Industry Center > Drugs - Generic > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drugs - Generic News
Latest News
Friday, Apr 17, 2015
·Research Reports
at Barrons.com - Fri 11:41 pm ET
·5 ETF Trends To Watch As Assets, Strategies Multiply
at Investor's Business Daily, Inc. - Fri 8:04 pm ET
·Diplomat Launches National Search for Internship and Fellowship in Flint
PR Newswire - Fri 4:30 pm ET
·Karyopharm to Present Late-Breaking Data at American Association for Cancer Research Annual Meeting
GlobeNewswire - Fri 4:30 pm ET
·Elton John AIDS Foundation joins forces with the Mylan Relay for Hope to accelerate the fight against HIV/AIDS
PR Newswire - Fri 3:54 pm ET
·Mylan (MYL) Stock Spikes in Afternoon Trading on Teva Takeover Speculation
at TheStreet.com - Fri 3:35 pm ET
·Mylan says merger with Teva would be bad fit
Reuters - Fri 3:31 pm ET
·Mylan to Teva: Thanks but no thanks, we'll stay independent
at bizjournals.com - Fri 3:13 pm ET
·Mylan Comments on Recent Media Speculation
PR Newswire - Fri 2:45 pm ET
·Teva considering potential bid for Mylan - Bloomberg
Reuters - Fri 2:37 pm ET
·Federal Circuit Upholds Mylan's U.S. Patents on Perforomist® Inhalation Solution; Decision Prevents Approval of Teva ANDA
PR Newswire - Fri 12:55 pm ET
·Mallinckrodt details management shift in Ikaria merger
at bizjournals.com - Fri 12:54 pm ET
·Fibrocell Science to Present at World Orphan Drug Congress USA 2015
GlobeNewswire - Fri 8:05 am ET
·Momenta Pharmaceuticals Announces Data Presentations on Glatopa(TM) (glatiramer acetate injection) at the American Academy of Neurology's (AAN) 2015 Annual Meeting
GlobeNewswire - Fri 8:00 am ET
·Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering PENNSAID(R) 2%
Marketwire - Fri Apr 17
Thursday, Apr 16, 2015
·FDA Approves Generic Copaxone, but When Will it Become Available?
at The Wall Street Journal Online - Thu Apr 16
·Citi Sees Limited Sales For Blood-Clot Drug At The Medicines Company
- Thu Apr 16
·Horizon Pharma (HZNP) Stock Rises in After-Hours Trading Following Pricing of Secondary Offering
at TheStreet.com - Thu Apr 16
·Diplomat Names Shannon M. Beltrand as New CISO
PR Newswire - Thu Apr 16
·FDA Approves Generic MS Drug by Novartis and Momenta
at The Wall Street Journal Online - Thu Apr 16
More Latest News...
Sponsor Results
College Degree Online
Get Degree With $5,730 University or College Grant if Qualify. Act Now.
Degree-Accredited.com/Institute
M/A/R/C Research
Custom Research
www.MARCresearch.com
Search Medical
Find Medical Information Here at Local.com!
Local.com
(What's This?)
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drugs - Generic Headlines
More Finance RSS Feeds


Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2015, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?